BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

307 related articles for article (PubMed ID: 33877299)

  • 1. Prevalence, predictors, and outcomes of clonal hematopoiesis in individuals aged ≥80 years.
    van Zeventer IA; Salzbrunn JB; de Graaf AO; van der Reijden BA; Boezen HM; Vonk JM; van der Harst P; Schuringa JJ; Jansen JH; Huls G
    Blood Adv; 2021 Apr; 5(8):2115-2122. PubMed ID: 33877299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Full spectrum of clonal haematopoiesis-driver mutations in chronic heart failure and their associations with mortality.
    Kiefer KC; Cremer S; Pardali E; Assmus B; Abou-El-Ardat K; Kirschbaum K; Dorsheimer L; Rasper T; Berkowitsch A; Serve H; Dimmeler S; Zeiher AM; Rieger MA
    ESC Heart Fail; 2021 Jun; 8(3):1873-1884. PubMed ID: 33779075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations.
    Assmus B; Cremer S; Kirschbaum K; Culmann D; Kiefer K; Dorsheimer L; Rasper T; Abou-El-Ardat K; Herrmann E; Berkowitsch A; Hoffmann J; Seeger F; Mas-Peiro S; Rieger MA; Dimmeler S; Zeiher AM
    Eur Heart J; 2021 Jan; 42(3):257-265. PubMed ID: 33241418
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Monocytosis and its association with clonal hematopoiesis in community-dwelling individuals.
    van Zeventer IA; de Graaf AO; Koorenhof-Scheele TN; van der Reijden BA; van der Klauw MM; Dinmohamed AG; Diepstra A; Schuringa JJ; Malcovati L; Huls G; Jansen JH
    Blood Adv; 2022 Jul; 6(14):4174-4184. PubMed ID: 35561316
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mutational spectrum and dynamics of clonal hematopoiesis in anemia of older individuals.
    van Zeventer IA; de Graaf AO; Wouters HJCM; van der Reijden BA; van der Klauw MM; de Witte T; Jonker MA; Malcovati L; Jansen JH; Huls G
    Blood; 2020 Apr; 135(14):1161-1170. PubMed ID: 32243522
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Association of Clonal Hematopoiesis of Indeterminate Potential With Inflammatory Gene Expression in Patients With Severe Degenerative Aortic Valve Stenosis or Chronic Postischemic Heart Failure.
    Abplanalp WT; Mas-Peiro S; Cremer S; John D; Dimmeler S; Zeiher AM
    JAMA Cardiol; 2020 Oct; 5(10):1170-1175. PubMed ID: 32639511
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clonal Hematopoiesis Before, During, and After Human Spaceflight.
    Mencia-Trinchant N; MacKay MJ; Chin C; Afshinnekoo E; Foox J; Meydan C; Butler D; Mozsary C; Vernice NA; Darby C; Schatz MC; Bailey SM; Melnick AM; Guzman ML; Bolton K; Braunstein LZ; Garrett-Bakelman F; Levine RL; Hassane DC; Mason CE
    Cell Rep; 2020 Dec; 33(10):108458. PubMed ID: 33242405
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Review of clonal hematopoiesis, subtypes and its role in neoplasia and different morbidities.
    Younes IE; Syler L; Hamed A
    Leuk Res; 2023 Jul; 130():107307. PubMed ID: 37186988
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevalence and prognostic significance of DNMT3A- and TET2- clonal haematopoiesis-driver mutations in patients presenting with ST-segment elevation myocardial infarction.
    Wang S; Hu S; Luo X; Bao X; Li J; Liu M; Lv Y; Zhao C; Zeng M; Chen X; Unsworth A; Jones S; Johnson TW; White SJ; Jia H; Yu B
    EBioMedicine; 2022 Apr; 78():103964. PubMed ID: 35339897
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Compartment-specific mutational landscape of clonal hematopoiesis.
    Hartmann L; Hecker JS; Rothenberg-Thurley M; Rivière J; Jentzsch M; Ksienzyk B; Buck MC; van der Garde M; Fischer L; Winter S; Rauner M; Tsourdi E; Weidner H; Sockel K; Schneider M; Kubasch AS; Nolde M; Hausmann D; Lützner J; Goralski S; Bassermann F; Spiekermann K; Hofbauer LC; Schwind S; Platzbecker U; Götze KS; Metzeler KH
    Leukemia; 2022 Nov; 36(11):2647-2655. PubMed ID: 36131041
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clonal hematopoiesis as determined by the HUMARA assay is a marker for acquired mutations in epigenetic regulators in older women.
    Wiedmeier JE; Kato C; Zhang Z; Lee H; Dunlap J; Nutt E; Rattray R; McKay S; Eide C; Press R; Mori M; Druker B; Dao KH
    Exp Hematol; 2016 Sep; 44(9):857-865.e5. PubMed ID: 27235757
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical relevance of clonal hematopoiesis and its interference in cell-free DNA profiling of patients with gastric cancer.
    Lee KS; Lee CK; Kwon SS; Kwon WS; Park S; Lee ST; Choi JR; Rha SY; Shin S
    Clin Chem Lab Med; 2024 Jan; 62(1):178-186. PubMed ID: 37435889
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A macaque clonal hematopoiesis model demonstrates expansion of TET2-disrupted clones and utility for testing interventions.
    Shin TH; Zhou Y; Chen S; Cordes S; Grice MZ; Fan X; Lee BC; Aljanahi AA; Hong SG; Vaughan KL; Mattison JA; Kohama SG; Fabre MA; Uchida N; Demirci S; Corat MAF; Métais JY; Calvo KR; Buscarlet M; Natanson H; McGraw KL; List AF; Busque L; Tisdale JF; Vassiliou GS; Yu KR; Dunbar CE
    Blood; 2022 Oct; 140(16):1774-1789. PubMed ID: 35714307
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clonal hematopoiesis and cardiovascular disease: deciphering interconnections.
    Stein A; Metzeler K; Kubasch AS; Rommel KP; Desch S; Buettner P; Rosolowski M; Cross M; Platzbecker U; Thiele H
    Basic Res Cardiol; 2022 Nov; 117(1):55. PubMed ID: 36355225
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer patients with clonal hematopoiesis die from primary malignancy or comorbidities despite higher rates of transformation to myeloid neoplasms.
    Chien KS; Ong F; Kim K; Li Z; Kanagal-Shamanna R; DiNardo CD; Takahashi K; Montalban-Bravo G; Hammond D; Sasaki K; Pierce SA; Kantarjian HM; Garcia-Manero G
    Cancer Med; 2024 Mar; 13(5):e7093. PubMed ID: 38497538
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Clinical, Mutational, and Transcriptomic Characteristics in Elderly Korean Individuals With Clonal Hematopoiesis Driver Mutations.
    Moon I; Kong MG; Ji YS; Kim SH; Park SK; Suh J; Jang MA
    Ann Lab Med; 2023 Mar; 43(2):145-152. PubMed ID: 36281508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High prevalence of clonal hematopoiesis in the blood and bone marrow of healthy volunteers.
    Guermouche H; Ravalet N; Gallay N; Deswarte C; Foucault A; Beaud J; Rault E; Saindoy E; Lachot S; Martignoles JA; Gissot V; Suner L; Gyan E; Delhommeau F; Herault O; Hirsch P
    Blood Adv; 2020 Aug; 4(15):3550-3557. PubMed ID: 32761230
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Age-related clonal hematopoiesis associated with adverse outcomes.
    Jaiswal S; Fontanillas P; Flannick J; Manning A; Grauman PV; Mar BG; Lindsley RC; Mermel CH; Burtt N; Chavez A; Higgins JM; Moltchanov V; Kuo FC; Kluk MJ; Henderson B; Kinnunen L; Koistinen HA; Ladenvall C; Getz G; Correa A; Banahan BF; Gabriel S; Kathiresan S; Stringham HM; McCarthy MI; Boehnke M; Tuomilehto J; Haiman C; Groop L; Atzmon G; Wilson JG; Neuberg D; Altshuler D; Ebert BL
    N Engl J Med; 2014 Dec; 371(26):2488-98. PubMed ID: 25426837
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.
    Genovese G; Kähler AK; Handsaker RE; Lindberg J; Rose SA; Bakhoum SF; Chambert K; Mick E; Neale BM; Fromer M; Purcell SM; Svantesson O; Landén M; Höglund M; Lehmann S; Gabriel SB; Moran JL; Lander ES; Sullivan PF; Sklar P; Grönberg H; Hultman CM; McCarroll SA
    N Engl J Med; 2014 Dec; 371(26):2477-87. PubMed ID: 25426838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clonal hematopoiesis confers an increased mortality risk in orthotopic heart transplant recipients.
    Scolari FL; Brahmbhatt DH; Abelson S; Medeiros JJF; Anker MS; Fung NL; Otsuki M; Calvillo-Argüelles O; Lawler PR; Ross HJ; Luk AC; Anker S; Dick JE; Billia F
    Am J Transplant; 2022 Dec; 22(12):3078-3086. PubMed ID: 35971851
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.